Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica K Altman

Showing results (31-40 of 166) with videos related to

Pageof 17
Sort By:
Plos One|November 22, 2013
Regulatory effects of sestrin 3 (SESN3) in BCR-ABL expressing cellsEliza Vakana, Ahmet Dirim Arslan, Amy Szilard, et al.
Blood|October 25, 2011
Antileukemic effects of AMPK activators on BCR-ABL-expressing cellsEliza Vakana, Jessica K Altman, Heather Glaser, et al.
Best Practice & Research. Clinical Haematology|March 17, 2009
The coagulopathy of acute promyelocytic leukaemia revisitedEytan Stein, Brandon McMahon, Hau Kwaan, et al.
The Journal of Biological Chemistry|June 11, 2011
Protein kinase R as mediator of the effects of interferon (IFN) gamma and tumor necrosis factor (TNF) alpha on normal and dysplastic hematopoiesisBhumika Sharma, Jessica K Altman, Dennis J Goussetis, et al.
Leukemia & Lymphoma|December 23, 2025
Donor-derived acute myeloid leukemia after solid organ transplant: evidence for leukemic stem cell transmissionAlok Swaroop, Timothy Oh, Kristy Wolniak, et al.
The Journal of Biological Chemistry|January 29, 2008
Suppression of programmed cell death 4 (PDCD4) protein expression by BCR-ABL-regulated engagement of the mTOR/p70 S6 kinase pathwayNathalie Carayol, Efstratios Katsoulidis, Antonella Sassano, et al.
Leukemia Research|October 20, 2010
Charcot-Leyden crystals associated with acute myeloid leukemia: case report and literature reviewPolina Khrizman, Jessica K Altman, Arash Mohtashamian, et al.
Hematology/Oncology Clinics of North America|November 19, 2011
Curing all patients with acute promyelocytic leukemia: are we there yet?Muhamed Baljevic, Jae H Park, Eytan Stein, et al.
Cancer Biology & Therapy|March 25, 2015
Targeting mTOR signaling pathways and related negative feedback loops for the treatment of acute myeloid leukemiaBenedito A Carneiro, Jason B Kaplan, Jessica K Altman, et al.
Cancer Medicine|December 19, 2020
The impact of FLT3 mutation clearance and treatment response after gilteritinib therapy on overall survival in patients with FLT3 mutation-positive relapsed/refractory acute myeloid leukemiaJessica K Altman, Alexander E Perl, Jason E Hill, et al.
Pageof 17

Showing results (31-40 of 166) with videos related to

Sort By:
Pageof 17
Plos One|November 22, 2013
Regulatory effects of sestrin 3 (SESN3) in BCR-ABL expressing cellsEliza Vakana, Ahmet Dirim Arslan, Amy Szilard, et al.
Blood|October 25, 2011
Antileukemic effects of AMPK activators on BCR-ABL-expressing cellsEliza Vakana, Jessica K Altman, Heather Glaser, et al.
Best Practice & Research. Clinical Haematology|March 17, 2009
The coagulopathy of acute promyelocytic leukaemia revisitedEytan Stein, Brandon McMahon, Hau Kwaan, et al.
The Journal of Biological Chemistry|June 11, 2011
Protein kinase R as mediator of the effects of interferon (IFN) gamma and tumor necrosis factor (TNF) alpha on normal and dysplastic hematopoiesisBhumika Sharma, Jessica K Altman, Dennis J Goussetis, et al.
Leukemia & Lymphoma|December 23, 2025
Donor-derived acute myeloid leukemia after solid organ transplant: evidence for leukemic stem cell transmissionAlok Swaroop, Timothy Oh, Kristy Wolniak, et al.
The Journal of Biological Chemistry|January 29, 2008
Suppression of programmed cell death 4 (PDCD4) protein expression by BCR-ABL-regulated engagement of the mTOR/p70 S6 kinase pathwayNathalie Carayol, Efstratios Katsoulidis, Antonella Sassano, et al.
Leukemia Research|October 20, 2010
Charcot-Leyden crystals associated with acute myeloid leukemia: case report and literature reviewPolina Khrizman, Jessica K Altman, Arash Mohtashamian, et al.
Hematology/Oncology Clinics of North America|November 19, 2011
Curing all patients with acute promyelocytic leukemia: are we there yet?Muhamed Baljevic, Jae H Park, Eytan Stein, et al.
Cancer Biology & Therapy|March 25, 2015
Targeting mTOR signaling pathways and related negative feedback loops for the treatment of acute myeloid leukemiaBenedito A Carneiro, Jason B Kaplan, Jessica K Altman, et al.
Cancer Medicine|December 19, 2020
The impact of FLT3 mutation clearance and treatment response after gilteritinib therapy on overall survival in patients with FLT3 mutation-positive relapsed/refractory acute myeloid leukemiaJessica K Altman, Alexander E Perl, Jason E Hill, et al.
Pageof 17